SynthesisOncotarget2017

An early biomarker and potential therapeutic target of RUNX 3 hypermethylation in breast cancer, a system review and meta-analysis.

De-Guo Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.